7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(N-methyl-N-methylsulfonyl-amino)-pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoic acid ethyl es ter

CAS: 851443-04-4

Ref. 3D-FF35383

Informação sobre produto

• Nome: 7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(N-methyl-N-methylsulfonyl-amino)-pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoic acid ethyl es ter
• Sinónimos: Rosuvastatin Ethyl Ester, 7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-(N-methyl-N-methylsulfonyl-amino)-pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoic acid ethyl ester, Rosuvastatine, ethyl (3R,5S,6E)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate
• CAS: 851443-04-4

Descrição

Rosuvastatin is a statin drug that inhibits cholesterol synthesis by inhibiting the enzyme HMG-CoA reductase. Rosuvastatin has been shown to reduce high-sensitivity C-reactive protein (hsCRP) and low-density lipoprotein cholesterol (LDL-C), which are risk factors for cardiovascular disease, in patients with hypercholesterolemia. Rosuvastatin also has a high degree of potency and specificity for the HMG-CoA reductase enzyme and shows no significant cross-reactivity with other HMG-CoA reductase inhibitors. Rosuvastatin is metabolized by CYP3A4 and CYP2C9. Drugs that inhibit these enzymes may increase the plasma levels of rosuvastatin, while drugs that induce these enzymes may decrease the plasma levels of rosuvastatin.

• Marca: Biosynth

Propriedades químicas

• Peso molecular: 509.59 g/mol
• Fórmula: C₂₄H₃₂FN₃O₆S
• Pureza: Min. 95%
• Cor/forma: White Powder